Congenital hemangioma is caused by malformation of blood vessel tissue or dilatation of existing blood vessels during fetal life. Traditional treatment methods such as laser, freezing, radiation, surgery, etc., however, all have to leave large or small scars, especially in some special areas and may also affect the function, while today some hemangiomas can be treated with medication to achieve very desirable treatment results, which are written down for you to share and also provide gospel for patients with hemangioma. Congenital hemangioma is clinically divided into three types: (a) nevus flammeus, also known as nevus capillaris or nevus of wine. It can be present at birth. It occurs on the face and neck, but can also occur in any other parts of the body. The lesion is a rash or patch, not higher than the skin surface, light red or dark red in color, irregular in shape, and partially or completely discolored when pressed. If the lesions occur on the face, they may darken with age and may be raised above the skin surface or nodular lesions may occur on them. It may be accompanied by other vascular malformations, such as arachnoid hemangioma of the soft meninges, conjunctival, iris or choroidal hemangioma, which may lead to glaucoma or retinal detachment. (B) Strawberry hemangioma, also known as capillary hemangioma, can exist at birth but often occurs within 2 to 3 months after birth. It occurs on the face, shoulders, head and neck. The lesions are bright red lobulated tumors, soft, raised above the skin surface, clearly defined, single or several, usually 1 to several centimeters, and occasionally the entire limb is involved; deeper parts of the extensive lesions are often associated with cavernous hemangiomas. The lesions may gradually increase in size and gradually begin to degenerate after about 1 year, with 70% to 90% of patients completely regressing on their own by the age of 5 to 7 years. (C) cavernous hemangioma (cavernous hemangioma) is present at birth or occurs several weeks after birth. It occurs in the head and neck, and may also involve other parts of the mucosa of the mouth or pharynx. The lesions are single or several large irregular nodular or lobulated superficial lesions with bright red or dark red color, irregular surface, deep in the lesions with purple color, indistinct boundary, soft and elastic, compressible, and sponge-like. The lesions gradually increase in size within a year and may also gradually remit, but are difficult to completely subside. Involvement of the gastrointestinal tract often causes chronic bleeding and anemia, and autopsy also reveals involvement of other organs. From 2008, Léauté-Labrèze et al. in France found that the use of propranolol (Propranolol) could treat hemangioma. Many studies at home and abroad subsequently confirmed the efficacy of Propranolol in treating IH, but patients’ families were afraid to try it because they were worried that systemic medication would cause side effects to children’s cardiovascular system. Nowadays, they usually take the medication in the hospital for a week to observe no side effects before they go home to continue taking the medication and follow up regularly. In this regard, we have performed topical treatment of body surface hemangioma with the solution of insulin and achieved good results, avoiding the side effects of systemic medication while ensuring efficacy. However, not all types are suitable for this method; vascular malformations have no obvious efficacy, and the specific drug concentration needs to be formulated by the doctor according to the condition. We hope that all patients with hemangioma will have a good recovery.